Rapid decrease in lung cancer and melanoma deaths lead overall continued decline in cancer death rate
On Jul. 8, 2021, the National Institutes of Health (NIH) reported that the overall cancer death rates continue…
NIH study associated COVID-19 surged with mortality increases for patients
On Jul. 8, 2021, the National Institutes of Health (NIH) announced that a new study authored by scientists…
Collaboration created worldï¾’s largest browsable resource linking rare protein-coding genetic variants to human disease
On Jul. 8, 2021, access to the worldï¾’s largest browsable resource linking rare protein-coding genetic variants to human…
Pfizer and BioNTech provided update on booster program in light of the Delta-variant
On Jul. 8, 2021, Pfizer and BioNTech announced encouraging data in the ongoing booster trial of a third…
Rice, Rutgers announced development of inhalable COVID-19 vaccine spray
On Jul. 7, 2021, Rice University announced a study to develop an inhalable COVID-19 vaccine. The project led…
WHO recommended interleukin-6 receptor blockers for COVID-19 and urged producers to join efforts to rapidly increase access
On Jul. 6, 2021, the World Health Organization announced updated patient care guidelines to include interleukin-6 receptor blockers,…
Dynavax and Biological E announced agreement of Dynavax’s CpG 1018 adjuvant for Biological E’s COVID-19 vaccine candidate
On Jul. 6, 2021, Dynavax Technologies and Biological E announced the execution of a commercial supply agreement of…
Becton Dickinson and CerTest teamed up to detect covid-19 in saliva
On Jul. 5, 2021, CerTest Biotec and BD announces addition of saliva to the CE Marked VIASURE SARS-CoV-2…
NIH COVID-19 testing initiative funded additional research projects to safely return children to in-person school
On Jul. 2, 2021, the National Institutes of Health funding five additional projects to identify ways of safely…
U.S. FDA authorized an EUA for the Janssen COVID-19 vaccine manufacture at Emergent facility
On Jul. 2, 2021, the Food and Drug Administration (FDA) authorized the use, under the emergency use authorization…
Moderna announced Recipharm site in France manufacturing COVID-19 Vaccine following approval by EMA
On Jul. 1, 2021, Moderna confirmed that following the European Medicines Agencyï¾’s (EMA) Committee for Human Medicines (CHMP)…
HDT Bio received notice to proceed from FDA for U.S. phase 1 clinical trial of RNA COVID-19 vaccine
On Jul. 1, 2021, HDT Bio announced the U.S. Food and Drug Administration had reviewed the companyï¾’s Investigational…
Ateaï¾’s AT-527 oral antiviral drug candidate reduced viral replication in hospitalized patients with COVID-19
On Jun. 30, 2021, Atea Pharmaceuticals announced positive interim results from the global Phase 2 study evaluating AT-527…
NIH-funded screening study builds case for frequent COVID-19 antigen testing
On Jun. 30, 2021, the National Institutes of Health announced a highly anticipated study that compared rapid antigen…
CureVac announced final data from phase 2b/3 trial of first-generation COVID-19 vaccine candidate, CVnCoV
On Jun. 30, 2021, CureVac announced results from the final analysis of its 40,000 subject international pivotal Phase…
Investigational malaria vaccine gives strong, lasting protection
On Jun. 30, 2021, the National Institutes of Health announced that two U.S. Phase 1 clinical trials of…
From 30 million cases to zero: China certified malaria-free by WHO
On Jun. 30, 2021, following a 70-year effort, China was awarded a malaria-free certification from the World Health…
XPhyto supplied 10 test centers in Berlin with 25-minute COVID-19 PCR test
On Jun. 30, 2021, XPhyto announced that it had signed a master supply agreement with Beovita and Tackleberries,…
Novavax published results of UK phase 3 clinical trial in NEJM, demonstrating high levels of efficacy of COVID-19 vaccine
On Jun. 30, 2021, Novavax announced the publication of results from the final analysis of a pivotal Phase…
SIGA supplied TPOXX (Tecovirimat) as compassionate treatment for Monkeypox case in the UK
On Jun. 30, 2021, SIGA Technologies announced that it had provided TPOXX (tecovirimat) to Liverpool University Hospitals NHS…
Gavi signed agreement with Clover Biopharmaceuticals for supply to COVAX
On Jun. 30, 2021, Gavi, the Vaccine Alliance, that it had signed an advance purchase agreement with Clover…
Fostamatinib selected for NIH ACTIV-4 COVID-19 clinical trial
On Jun. 29, 2021, Rigel Pharma announced that fostamatinib, the Company’s novel oral spleen tyrosine kinase (SYK) inhibitor,…
Adjuvant developed with NIH funding enhanced efficacy of Indiaï¾’s COVID-19 vaccine
On Jun. 29, 2021, the National Institutes of Health announced that an adjuvant developed with its funding had…
Paratek announced first BARDA Project BioShield procurement of NUZYRAï¾® (omadacycline)
On Jun. 29, 2021, Paratek Pharmaceuticals announced it had delivered the first procurement of NUZYRA to the Biomedical…
Moderna provides a clinical update on neutralizing activity of COVID-19 vaccine on emerging variants
On Jun. 29, 2021, Moderna announced new results from in vitro neutralization studies of sera from individuals vaccinated…
Moderna announces Emergency Use Authorization for its COVID-19 vaccine granted by Government of India
On Jun. 29, 2021, Moderna announced that the government of India had issued a registration certificate and a…
Altimmune announced update on AdCOVIDï¾™ phase 1 clinical trial
On Jun. 29, 2021, Altimmune announced phase 1 AdCOVID clinical trial data that showed AdCOVID appeared to be…
VBI Vaccines announced initial positive phase 1 data for its eVLP vaccine candidate against COVID-19
On Jun. 29, 2021, VBI Vaccines announced positive Phase 1 data from its Phase 1/2 trial of the…
First trial participants vaccinated with Oxford COVID-19 variant vaccine
On Jun. 28, 2021, the University of Oxford in partnership with AstraZeneca began vaccinations for a new phase…
Mixed Oxford/Pfizer vaccine schedules generated robust immune response against COVID-19
On Jun. 28, 2021, researchers running the University of Oxford-led Com-COV study reported that alternating doses of the…